浏览全部资源
扫码关注微信
Traditional Chinese Medicine Targets mTOR Signaling Pathway for Treatment of Diabetic Kidney Disease： A Review
增强出版- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 22, Pages: 223-230(2023)
- 作者机构：
1.陕西中医药大学 第一临床医学院，陕西 咸阳 712046
2.陕西省中医医院，西安 710003
- 作者简介：
- 基金信息：
DOI：10.13422/j.cnki.syfjx.20231242
CLC： R2-0;R33;R587.1;R692;G353.11Published：20 November 2023，
Published Online：07 September 2023，
Received：12 July 2023，
- 稿件说明：
扫 描 看 全 文
张薇,周荣,董凯旋等.中医药靶向mTOR信号通路治疗糖尿病肾病的研究进展[J].中国实验方剂学杂志,2023,29(22):223-230.
ZHANG Wei,ZHOU Rong,DONG Kaixuan,et al.Traditional Chinese Medicine Targets mTOR Signaling Pathway for Treatment of Diabetic Kidney Disease： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(22):223-230.
张薇,周荣,董凯旋等.中医药靶向mTOR信号通路治疗糖尿病肾病的研究进展[J].中国实验方剂学杂志,2023,29(22):223-230. DOI： 10.13422/j.cnki.syfjx.20231242.
ZHANG Wei,ZHOU Rong,DONG Kaixuan,et al.Traditional Chinese Medicine Targets mTOR Signaling Pathway for Treatment of Diabetic Kidney Disease： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(22):223-230. DOI： 10.13422/j.cnki.syfjx.20231242.
摘要
糖尿病肾病（DKD）是作为糖尿病（DM）常见并发症之一，是一种出现特定肾脏病理结构和功能改变的慢性肾脏病（CKD）。大多数学者认为，DKD发病机制与糖代谢紊乱、氧化应激、炎症反应、内质网应激、细胞自噬、脂代谢紊乱及外泌体调控等因素有关。现代研究发现，哺乳动物雷帕霉素靶蛋白（mTOR）相关信号通路在DKD中起着关键作用，可以维持肾小球足细胞稳态，参与DKD细胞自噬、肾纤维化、氧化应激、脂代谢紊乱、炎症反应等过程，是当代治疗DKD的新型靶点。越来越多的研究表明，中医药能通过调节mTOR信号通路抑制DKD肾组织损伤，延缓DKD进一步恶化，改善疾病预后，提升患者生活水平。该文通过总结mTOR相关信号通路结构与机制，详述其在DKD中的作用，并对近年来中药单体、中药相关提取物及中药复方通过该信号通路防治DKD的研究现状作简要综述，以期为中医药临床治疗DKD提供新思路与方式。
Abstract
Diabetic kidney disease （DKD）， a chronic kidney disease with unique pathological structural and functional alterations in the kidney， is a common complication of diabetes mellitus （DM）. The majority of researchers believe that the occurrence of this disease is associated with glucose metabolism disorders， oxidative stress， inflammation， endoplasmic reticulum stress， autophagy， and disorders of lipid metabolism and exosome release. The mammalian target of rapamycin （mTOR） signaling pathway， which can maintain glomerular podocyte homeostasis and participate in autophagy， renal fibrosis， oxidative stress， lipid metabolism disorders， and inflammatory response in DKD， has been discovered to play a key role in DKD. Therefore， it has emerged as a novel target for the treatment of DKD. Studies have demonstrated that traditional Chinese medicine can prevent the renal damage in DKD by regulating the mTOR signaling pathway to delay the disease progression and improve the prognosis and the quality of life of the patients. This article summarizes the structure and role of the mTOR signaling pathway in DKD and briefs the research progress in the prevention and treatment of DKD via this signaling pathway by the active components， extracts， and compound prescriptions of Chinese medicines， aiming to present new ideas and approaches for the clinical treatment of DKD with traditional Chinese medicine.
关键词
糖尿病肾病哺乳动物雷帕霉素靶蛋白（mTOR）中药信号通路综述
Keywords
diabetic kidney diseasemammalian target of rapamycin （mTOR）Chinese medicinesignaling pathwayreview
references
ALICIC R Z，ROONEY M T，TUTTLE K R.Diabetic kidney disease：Challenges， progress， and possibilities［J］.Clin J Am Soc Nephrol，2017，12（12）：2032-2045.
THOMAS M C，BROWNLEE M，SUSZTAK K，et al.Diabetic kidney disease［J］.Nat Rev Dis Primers，2015，1：15018.
魏晓，欧三桃.综合防治，延缓进展——2014年版《中国糖尿病肾病防治专家共识》解读［J］.实用医学杂志，2016，32（1）：1-3.
梁静妍， 吴东阳， 孙一铭， 等. 中医药防治糖尿病肾脏病肾小管损伤的研究进展［J］. 中国实验方剂学杂志， 2022，28（24）：261-273.
LIU X J，HU X K，YANG H，et al.A review of traditional Chinese medicine on treatment of diabetic nephropathy and the involved mechanisms［J］.Am J Chin Med，2022，50（7）：1739-1779.
LU Z，ZHONG Y，LIU W，et al.The efficacy and mechanism of Chinese herbal medicine on diabetic kidney disease［J］.J Diabetes Res，2019，2019：2697672.
HUBER T B，WALZ G，KUEHN E W.mTOR and rapamycin in the kidney：Signaling and therapeutic implications beyond immunosuppression［J］.Kidney Int，2011，79（5）：502-511.
LI D，LU Z，XU Z，et al.Spironolactone promotes autophagy via inhibiting PI3K/Akt/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress［J］.Biosci Rep，2016，36（4）：e00355.
DAI H，LIU Q，LIU B.Research progress on mechanism of podocyte depletion in diabetic nephropathy［J］.J Diabetes Res，2017，2017：2615286.
YUAN T，RAFIZADEH S，GORREPATI K D，et al.Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes［J］.Diabetologia，2017，60（4）：668-678.
LU Q，ZHOU Y，HAO M，et al.The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy［J］.Mol Cell Endocrinol，2018，473：31-43.
LIU G Y，SABATINI D M.mTOR at the nexus of nutrition， growth， ageing and disease［J］.Nat Rev Mol Cell Biol，2020，21（4）：183-203.
FANTUS D，ROGERS N M，GRAHAMMER F，et al.Roles of mTOR complexes in the kidney：Implications for renal disease and transplantation［J］.Nat Rev Nephrol，2016，12（10）：587-609.
GUI Y，DAI C.mTOR signaling in kidney diseases［J］.Kidney360，2020，1（11）：1319-1327.
ERSAHIN T，TUNCBAG N，CETIN-ATALAY R.The PI3K/Akt/mTOR interactive pathway［J］.Mol Biosyst，2015，11（7）：1946-1954.
INOKI K，LI Y，ZHU T，et al.TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling［J］.Nat Cell Biol，2002，4（9）：648-657.
LIEBERTHAL W，LEVINE J S.The role of the mammalian target of rapamycin （mTOR） in renal disease［J］.J Am Soc Nephrol，2009，20（12）：2493-2502.
INOKI K，LI Y，XU T，et al.Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling［J］.Genes Dev，2003，17（15）：1829-1834.
GWINN D M，SHACKELFORD D B，EGAN D F，et al.AMPK phosphorylation of raptor mediates a metabolic checkpoint［J］.Mol Cell，2008，30（2）：214-226.
HAY N，SONENBERG N.Upstream and downstream of mTOR［J］.Genes Dev，2004，18（16）：1926-1945.
MAGNUSON B，EKIM B，FINGAR D C.Regulation and function of ribosomal protein S6 kinase （S6K） within mTOR signalling networks［J］.Biochem J，2012，441（1）：1-21.
GANLEY I G，LAM DU H，WANG J，et al.ULK1，ATG13，FIP200 complex mediates mTOR signaling and is essential for autophagy［J］.J Biol Chem，2009，284（18）：12297-12305.
GLICK D，BARTH S，MACLEOD K F.Autophagy：Cellular and molecular mechanisms［J］.J Pathol，2010，221（1）：3-12.
TAKAHASHI A，TAKABATAKE Y，KIMURA T，et al.Autophagy inhibits the accumulation of advanced glycation end products by promoting lysosomal biogenesis and function in the kidney proximal tubules［J］.Diabetes，2017，66（5）：1359-1372.
WANG G，YAN Y，XU N，et al.Upregulation of microRNA-424 relieved diabetic nephropathy by targeting Rictor through mTOR complex2/protein kinase B signaling［J］.J Cell Physiol，2019，234（7）：11646-11653.
HOSOKAWA N，HARA T，KAIZUKA T，et al.Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy［J］.Mol Biol Cell，2009，20（7）：1981-1991.
JUNG C H，JUN C B，RO S H，et al.ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery［J］.Mol Biol Cell，2009，20（7）：1992-2003.
SETTEMBRE C，FRALDI A，MEDINA D L，et al.Signals from the lysosome：A control centre for cellular clearance and energy metabolism［J］.Nat Rev Mol Cell Biol，2013，14（5）：283-296.
LIEBERTHAL W， LEVINE J S. Mammalian target of rapamycin and the kidney Ⅱ pathophysiology and therapeutic implications ［J］.Am J Physiol Renal Physiol，2012，303（2）：F180-F191.
ZHANG Y，WANG Y，LUO M，et al.Elabela protects against podocyte injury in mice with streptozocin-induced diabetes by associating with the PI3K/Akt/mTOR pathway［J］.Peptides，2019，114：29-37.
WANG X，GAO L，LIN H，et al.Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli［J］.Eur J Pharmacol，2018，824：170-178.
敖雅慧，曹文富.糖尿病肾病肾纤维化发病机制及治疗研究进展［J］.实用中医药杂志，2022，38（2）：326-331.
LU Q，WANG W W，ZHANG M Z，et al.ROS induces epithelial-mesenchymal transition via the TGF-β1/PI3K/Akt/mTOR pathway in diabetic nephropathy［J］.Exp Ther Med，2019，17（1）：835-846.
YU R，BO H，VILLANI V，et al.The inhibitory effect of rapamycin on Toll like receptor 4 and interleukin 17 in the early stage of rat diabetic nephropathy［J］.Kidney Blood Press Res，2016，41（1）：55-69.
ZHAO T，XIANG Q，LIE B，et al.Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/Akt/mTOR signaling pathways［J］.Heliyon，2023，9（3）：e14171.
张蕾，刘旭生.糖尿病肾病中医病名源流探索性研究［J］.辽宁中医杂志，2012，39（1）：52-54.
北京中医药大学东直门医院.消渴病肾病（糖尿病肾病）中医诊疗方案（2017年版）［J］.中国实用乡村医生杂志，2017，24（8）：66-68.
智猛，那俊夫，曹奇，等.基于中医气血理论探究AMPK/mTOR信号通路与自噬的关系［J］.中华中医药学刊，2023，41（3）：80-84.
OU Y，ZHANG W，CHEN S，et al.Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway［J］.Open Med （Wars），2021，16（1）：1286-1298.
KAMALAKKANNAN N，STANELY MAINZEN PRINCE P.The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney［J］.J Pharm Pharmacol，2006，58（8）：1091-1098.
DONG R，ZHANG X，LIU Y，et al.Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/Akt/mTOR pathway in diabetic kidney disease［J］.Phytomedicine，2023，112：154700.
LIAO J，LIU B，CHEN K，et al.Galangin attenuates oxidative stress-mediated apoptosis in high glucose-induced renal tubular epithelial cells through modulating renin-angiotensin system and PI3K/Akt/mTOR pathway［J］.Toxicol Res （Camb），2021，10（3）：551-560.
WEI L，JIAN P，ERJIONG H，et al.Ginkgetin alleviates high glucose-evoked mesangial cell oxidative stress injury，inflammation，and extracellular matrix （ECM） deposition in an AMPK/mTOR-mediated autophagy axis［J］.Chem Biol Drug Des，2021，98（4）：620-630.
SHENG H，ZHANG D，ZHANG J，et al.Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK/mTOR pathways［J］.Front Med （Lausanne），2022，9：986825.
ZHONG Y，LUO R，LIU Q，et al.Jujuboside A ameliorates high fat diet and streptozotocin induced diabetic nephropathy via suppressing oxidative stress， apoptosis， and enhancing autophagy［J］.Food Chem Toxicol，2022，159：112697.
CHEN Y，LIU Q，SHAN Z，et al.Catalpol ameliorates podocyte injury by stabilizing cytoskeleton and enhancing autophagy in diabetic nephropathy［J］.Front Pharmacol，2019，10：1477.
ZHONG Y，LIU J，SUN D，et al.Dioscin relieves diabetic nephropathy via suppressing oxidative stress and apoptosis， and improving mitochondrial quality and quantity control［J］.Food Funct，2022，13（6）：3660-3673.
张少泉，李鑫辉，倪向荣.知母皂苷元通过AMPK-mTOR-ULK1途径抑制肾小球系膜基质合成和激活自噬治疗糖尿病肾病的研究［J］.现代中西医结合杂志，2021，30（11）：1180-1186.
吴浩，符丽珍，赵勇，等.桔梗皂苷D通过介导PI3K/Akt/mTOR信号通路调节氧化应激改善糖尿病肾病模型大鼠肾损伤［J］.中国药理学与毒理学杂志，2022，36（3）：170-176.
QIAO S，LIU R，LV C，et al.Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway［J］.Free Radic Biol Med，2019，145：118-135.
HAN F，XUE M，CHANG Y，et al.Triptolide suppresses glomerular mesangial cell proliferation in diabetic nephropathy is associated with inhibition of PDK1/Akt/mTOR pathway［J］.Int J Biol Sci，2017，13（10）：1266-1275.
CHEN J，CUI Y，ZHANG N，et al.Oleanolic acid attenuated diabetic mesangial cell injury by activation of autophagy via miRNA-142-5p/PTEN signaling［J］.Cytotechnology，2019，71（5）：925-933.
NIE Y，FU C，ZHANG H，et al.Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/Akt pathway［J］.BMC Complement Med Ther，2020，20（1）：321.
WANG T，GAO Y，YUE R，et al.Ginsenoside Rg1 alleviates podocyte injury induced by hyperlipidemia via targeting the mTOR/NF-κB/NLRP3 axis［J］.Evid Based Complement Alternat Med，2020，2020：2735714.
LIU H，WANG Q，SHI G，et al.Emodin ameliorates renal damage and podocyte injury in a rat model of diabetic nephropathy via regulating AMPK/mTOR-mediated autophagy signaling pathway［J］.Diabetes Metab Syndr Obes，2021，14：1253-1266.
HU Y，WANG S X，WU F Y，et al.Effects and mechanism of Ganoderma lucidum polysaccharides in the treatment of diabetic nephropathy in streptozotocin-induced diabetic rats［J］.Biomed Res Int，2022，2022：4314415.
TAO M，ZHENG D，LIANG X，et al.Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway［J］.Mol Med Rep，2021，24（2）：592.
段凤阳，宋纯东，宋丹，等.雷公藤多苷对糖尿病肾病大鼠肾组织NFAT2/COX-2表达的影响［J］. 中国实验方剂学杂志，2023，29（5）：16-23.
LI C，GUAN X M，WANG R Y，et al.Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR/P70S6K/4EBP1 pathway［J］.Life Sci，2020，243：117277.
崔晓.小檗碱通过AMPK/mTOR通路调节自噬溶酶体功能改善糖尿病肾病的机制研究［D］.天津：天津医科大学，2020.
王晓伟，余小柱，郭二霞，等.蛇床子素通过PI3K/Akt/mTOR通路对糖尿病肾病大鼠纤维化及HSP90、SIRT1的影响［J］.中国老年学杂志，2023，43（6）：1446-1450.
CHEN L，DAI L，LIU Y，et al.Yiqi Huoxue recipe regulates autophagy through degradation of advanced glycation end products via mTOR/S6K1/LC3 pathway in diabetic nephropathy［J］.Evid Based Complement Alternat Med，2021，2021：9942678.
CHEN Y，ZHENG Y F，LIN X H，et al.Dendrobium mixture attenuates renal damage in rats with diabetic nephropathy by inhibiting the PI3K/Akt/mTOR pathway［J］.Mol Med Rep，2021，24（2）：590.
JIN D，LIU F，YU M，et al.Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway［J］.J Ethnopharmacol，2022，293：115246.
WU W， HU W， HAN W B， et al. Inhibition of Akt/mTOR/p70S6K signaling activity with Huangkui capsule alleviates the early glomerular pathological changes in diabetic nephropathy ［J］.Front Pharmacol，2018，doi：10.3389/fphar.2018.00443http://dx.doi.org/10.3389/fphar.2018.00443.
XUAN C， XI YM， ZHANG Y D， et al. Yiqi Jiedu Huayu decoction alleviates renal injury in rats with diabetic nephropathy by promoting autophagy ［J］. Front Pharmacol，2021，doi：10.3389/fphar.2021.624404http://dx.doi.org/10.3389/fphar.2021.624404.
WEN D， TAN R Z， ZHAO C Y， et al.Astragalus mongholicus Bunge and Panax notoginseng （Burkill） F.H. Chen formula for renal injury in diabetic nephropathy-in vivo and in vitro evidence for autophagy regulation［J］.Front Pharmacol，2020， doi：10.3389/fphar.2020.00732http://dx.doi.org/10.3389/fphar.2020.00732.
XU J， SHAN X， CHEN C， et al. Tangshenning attenuates high glucose-induced podocyte injury via restoring autophagy activity through inhibiting mTORC1 activation ［J］.J Diabetes Res，2022，doi：10.1155/2022/1610416http://dx.doi.org/10.1155/2022/1610416.
WANG X， ZHAO L， AJAY A K， et al. QiDiTangShen Granules activate renal nutrient-sensing associated autophagy in db/db mice ［J］. Front Physiol，2019，doi：10.3389/fphys.2019.01224http://dx.doi.org/10.3389/fphys.2019.01224.
列倍锋，程芳，段婷婷，等.黄芪散微丸对糖尿病肾病大鼠肾脏PI3K/Akt/mTOR通路及自噬的影响［J］.中国实验方剂学杂志，2022，28（7）：11-17.
0
Views
21
下载量
0
CSCD
- H-PDFDownload
- L-PDFDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Postal code：100700
- Tel：010-84076882 Email：syfjx_2010@188.com
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
